Intraperitoneal (IP) port cytology after completion of primary therapy for advanced stage ovarian cancer: A novel approach to a "second look".


Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA. Electronic address: [Email]


To determine whether IP port cytology predicts early recurrence and/or poor prognosis in patients with ovarian cancer who have completed primary therapy.


IP port,Ovarian cancer,Overall survival,Port cytology,Progression free survival,Survival,

OUR Recent Articles